Investor ‘pill’ for China’s healthcare reform
| Prompted by China’s efforts to reform healthcare and open the sector to more foreign investment, private-equity firms and medical institutions are looking to take advantage of the opportunities, report LINDA DENG in Seattle and WANG HONGYI in Shanghai.
T260 million Chinese suffer from cancer, diabetes and other chronic diseases. Almost one-third of the population, or 438 million, will be over 60 by 2050, more than double the current number of 178 million, according to the United Nations. 13,440 public hospitals provided 90 percent of the country’s medical services as of October 2013. There are 1.4 physicians per 1,000 people, compared to 2.4 in the United States, according to the World Health Organization. Beyond those numbers, China’s healthcare system also faces corruption, often volatile relations between doctors and patients, rising middle and upper-middle-class populations that seek and can afford more sophisticated medical services and a huge disparity between rural and urban healthcare.
Though China’s healthcare system has its merits, including cheap care and plenty of pharmaceuticals, the central government has made upgrading the system a priority – and an opportunity for foreign investors.
Last year, China boosted its annual budget for medical and healthcare spending to 260.25 billion yuan ($42.9 billion), a 27 percent increase from the previous year. The government said that it would raise medical subsidies for some non-working residents, extend a pilot insurance program for major diseases and accelerate reforms in public healthcare.
China’s medical-services market is growing 18 percent annually and is projected to reach $500 billion in 2015, said Deloitte China. And consulting firm McKinsey & Co said it expects total healthcare spending to hit $1 trillion by 2020.
he numbers are staggering:
Mergers and acquisitions in China’s healthcare sector rose to a record $11.3 billion in the first 11 months of this year, up 13 percent from $10 billion in the same period a year earlier, according to Dealogic data. And a number of deals have followed as a result of the central government’s liberalization policy.
Earlier this month, the private healthcareservice provider DeltaHealth reached an agreement with Columbia University’s cardiac surgery and cardiology division and Columbia HeartSource, to develop a heart center in Shanghai, the first of its kind in the city. It will explore the prevention and treatment of cardiovascular diseases, while also seeking to meet the specific needs of Chinese patients.
The 2013 China Cardiovascular Disease Report said that one in every five Chinese adults suffers from cardiovascular disease, while many others remain undiagnosed. It is a leading cause of 3.5 million deaths a year in China.
In September, the American private-equity firm TPG joined with a unit of the Fosun Group, a big Chinese investment company, in a $420 million deal to privatize Chindex International, a Nasdaq-listed operator of hospitals and clinics in China and Mongolia.
Chindex was founded by Americans Roberta Lipson and Elyse Beth Silverberg who moved to China in the late 1970s. It runs the United Family Healthcare chain of highend hospitals and clinics in cities, including Beijing, Shanghai and Guangzhou.
UPMC, a hospital operator based in Pittsburgh, Pennsylvania, and Massachusetts General Hospital in Boston, which is affiliated with Harvard University, recently said they had signed or were exploring deals to manage or build hospitals in China. Moving into China
After expansion over the past decade into Italy, Ireland, and the UK, UPMC announced in January that it was preparing to make its first move into China with “a wealth of potential projects’’.
“We are looking at China as one of our primary targets for expansion,” Chuck Bogosta, president of UPMC’s International and Commercial Services Division, wrote on its website. “To be a significant global health care provider, we know that we need to have a presence in the Asian market. The biggest challenge is finding the right partners.”
UPMC said it had hired Travis Tuto to head its Beijing office. Tu, who spent nine years in China working for other hospital companies, said, “China’s growing middle-class is starving for good, clean hospitals with patientcentered care and advanced technology.’’
On Nov 5, Seattle-based Columbia Pacific Management (CPM) — one of the largest healthcare providers in Asia — announced it was entering the China hospital market.
CPM has strong ties to China. In 2011, its China senior-care affiliate, Cascade Healthcare, became the first foreign-owned company to receive permission to build senior-care facilities in China and now as facilities in Beijing and Shanghai.
The first Columbia Asia hospital opened in Malaysia in 1994 and the network has grown to 26 hospitals in India and Southeast Asia. The hospitals are designed to serve Asia’s rapidly growing middle class with modern and efficient multispecialty hospitals located close to where patients live and work.
CPM said it is focusing on large cities in China (Shanghai with 24 million people, Wuxi with 7.5 million and Changzhou with 3.5 million), with hospitals and clinics designed to serve wide-ranging medical needs of the country’s fast-growing middle class.
The company’s new China hospital arm, Columbia China, will start construction next year on two 250-bed multi-specialty hospitals, in Wuxi and Changzhou, and is actively pursuing other hospital opportunities through acquisitions and greenfield projects. The 250-bed hospitals are in the permit stage, and both are expected to open by early 2018. Each hospital will cost $80 million to $100 million and each will have 600 to 800 employees. Outpatient clinics
To further bolster its presence in China as the hospitals are built, Columbia Pacific said it will also open several multi-specialty and specialty outpatient clinics under the Columbia China name.
The first clinic, the Columbia China United Plaza Clinic, will open this month in Shanghai’s central Puxi District. The 10,000-squarefoot multi-specialty clinic will provide internal medicine, pediatrics, rehabilitation and traditional Chinese medicine.
“We began in China with senior housing projects. Two years ago we started to look at building hospitals. The opportunity in China is tremendous for access to international quality healthcare service operators,’’ Nate McLemore, managing director of CPM, said in an interview with China Daily.
The international heart center by DeltaHealth, Columbia University’s cardiac surgery and cardiology division and Columbia HeartSource is expected to open in Shanghai in late 2015. Columbia University Medical Center in New York is one of the world’s leading medical institutions in cardiology and heart surgery and was ranked as one of the top three hospitals in cardiology and heart surgery by US News and World Report in 2014.
“We want to support China’s desire to improve private healthcare by playing a cooperative role in bringing together the best domestic and international resources in cardiovascular care to truly deliver a world-class, patient-focused heart hospital in China,” Daniel Auerbach, chairman of DeltaHealth’s board, said in an interview with China Daily in Shanghai.
Professionals from the Columbia University heart team will provide consultation and advice on developing high-quality clinical guidance and protocols, as well as physician and medical staff training and education in innovative cardiovascular procedures and patient care.
“The collaboration in developing the heart center will help explore an effective way of early intervention and assessment of medical outcomes that is unique to China,” Ge Junbo, a professor at the Chinese Academy of Sciences, said in an interview. He is also the chief adviser to the medical advisory panel at DeltaHealth.
Late last month, Shanghai-based venture capital and private-equity firm Trustbridge Partners broke ground on a $500 million general hospital in Shanghai. Shanghai Jiahui International Hospital is 100 percent privately owned by Trustbridge. When the first phase of the hospital is completed in 2017, it will have 246 beds, with phase 2 bringing the hospital’s capacity to 500 beds.
German hospital operator Artemed Group, Chinese property developers Vanke and Evergrande are also investing in Chinese hospitals.
In October, Massachusetts General Hospital said it was in early discussions with two partners to build a hospital with 500 to 1,000 beds in China. The hospital said it signed a “framework agreement’’ with a Chinese hospital that specializes in traditional medicine and a Chinese investment firm, allowing the three parties to exchange financial information and work on developing a definitive agreement to open a facility in an island city close to Hong Kong.
Mass. General executives said the talks were preliminary and a final decision had not been made about whether to participate in the project, but that they hope to do so by next summer, according to the Boston Globe.
Harvard Medical School’s-affiliated academic medical center would jointly manage the China hospital, with Mass. General and Guangdong Provincial Hospital of Traditional Chinese Medicine, a local healthcare provider. The hospital, which has a working name of MGH Hospital China, would be located in a special economic development zone on the island of Hengqin, part of the city of Zhuhai. The center would provide clinical care and support research and medical training programs. Catering to wealthy
China’s growing number of middle-class and wealthy citizens are an attractive option for a US hospital or medical organization seeking outside sources of revenue. But trying to popularize Western-style hospitals that cater to the elite in China would face hurdles, including a shortage of doctors at private hospitals.
While health authorities acknowledge the shortage, their focus is on getting more doctors for rural areas. The National Health and Family Planning Commission set targets in 2011 for increasing the numbers and quality of primary-care physicians in these areas by 2020, in part through improvements in education.
The difficulties in attracting Chinese doctors to the private sector go beyond government policy. Part of the problem is that doctors in most of China need permission from the state-owned hospitals where they practice before they can work in the private sector, and many public hospitals don’t want to let their best doctors go.
At a local level, public hospital leaders are often reluctant to even share their best doctors. Only in August did Beijing become the first municipality to let doctors work in more than one place without permission from their boss.
“Some government-owned hospitals are hampering doctors somewhat from going outside,” Charles Elcan, president of Chinaco Healthcare Corp (CHC), told Reuters in October 2014. CHC’s 500-bed hospital in the eastern city of Cixi admitted its first patient in July. “Some are very much open and support it, and some of them don’t,” added Elcan. “It’s an ongoing challenge.”
The Cixi hospital, a joint venture with local government, is operating at just a fifth of its capacity for in-patients, and is looking to recruit more doctors. CHC has invested close to $163 million in the project and is looking at other hospitals for acquisition and development.
The Trustbridge-invested hospital, known as Shanghai Jiahui International Hospital and due to be completed in 2017, planned to bring Chinese doctors from North America and use US management techniques to help reward and retain staff, said Gilbert Mudge, president of Boston-based hospital group Partners HealthCare International, which is a consultant to Jiahui. State-run insurance
In addition, private health-insurance products are almost entirely unavailable in China, making it hard for most Chinese to pay for services offered by foreign-owned private hospitals. “And China’s state-run insurance doesn’t cover Chindex’s care,’’ CRT Capital Group analyst Julie Chen said in an interview.
Chindex in 2006 launched a pilot insurance program, but at $5,000 per person per year, the annual premium is still too steep for most locals.
As a result, while almost half of China’s 24,700 hospitals are private most healthcare is still delivered by public institutions, with some 84 percent of in-patients using public facilities, according to a Deutsche Bank report in June.
“Investing in China’s health sector faces many challenges,’’ Yanzhon Huang, a senior fellow for global health at the Council on Foreign Relations, said in a New York Times article on Dec 10. But he added that more private investment would benefit the entire sector, including troubled state-funded hospitals.
“Increased competitive pressures would incentivize the public hospitals to kick off more meaningful reform efforts,’’ he said. “Private investment can play an important, even critical, role in China’s healthcare reform. Contact the writers at firstname.lastname@example.org and wanghongyi@chinadaily. com.cn
A preliminary rendering of Seattle-based Columbia Pacific’s planned hospital in the city of Wuxi, which will have 250 beds and cost $80 million to $100 million.